Fig. 2: Forest plots of ocular-related outcomes in patients with psoriasis treated with biologic versus non-biologic systemic therapies. | Eye

Fig. 2: Forest plots of ocular-related outcomes in patients with psoriasis treated with biologic versus non-biologic systemic therapies.

From: Biologic therapy is associated with reduced ocular disease in psoriasis: a real-world study

Fig. 2

Forest plots show hazard ratios (HRs) for glaucoma, cataract, and other ocular-related diagnoses (panels A–I) comparing patients with a confirmed diagnosis of psoriasis prescribed biologic agents with those prescribed non-biologic systemic treatments. Points represent HR estimates and horizontal lines indicate 95% confidence intervals. HRs are displayed on a logarithmic scale. AMD age-related macular degeneration.

Back to article page